Cimigenoside enhances Taxol chemosensitivity in triple-negative breast cancer via the γ-secretase/RBPJ-PXR axis.

Saved in:
Bibliographic Details
Title: Cimigenoside enhances Taxol chemosensitivity in triple-negative breast cancer via the γ-secretase/RBPJ-PXR axis.
Authors: Feng M; Department of Pathology and Pathophysiology, School of Basic Medical Sciences, Shenyang Medical College, Shenyang, China., Yang X; Department of Endocrinology, General Hospital of Northern Theater Command, Shenyang, China., Yao K; Department of Pathology and Pathophysiology, School of Basic Medical Sciences, Shenyang Medical College, Shenyang, China., Yang KF; Department of Pathology and Pathophysiology, School of Basic Medical Sciences, Shenyang Medical College, Shenyang, China., Zhan XY; School of Traditional Chinese Medicine, Shenyang Medical College, Shenyang, China., Zhou MS; Science and Experimental Research Center of Shenyang Medical College, Shenyang, China.; Shenyang Key Laboratory of Vascular Biology, Shenyang, China., Jia H; School of Traditional Chinese Medicine, Shenyang Medical College, Shenyang, China.; Shenyang Key Laboratory of Vascular Biology, Shenyang, China.
Source: British journal of pharmacology [Br J Pharmacol] 2026 Jul; Vol. 183 (13), pp. 3666-3684. Date of Electronic Publication: 2026 Apr 03.
Publication Type: Journal Article
Journal Info: Publisher: Wiley Country of Publication: England NLM ID: 7502536 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1476-5381 (Electronic) Linking ISSN: 00071188 NLM ISO Abbreviation: Br J Pharmacol Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1476-5381
DOI:10.1111/bph.70439